The Systemic Cytokine Environment Is Permanently Altered in Multiple Myeloma

PLoS ONE - United States
doi 10.1371/journal.pone.0058504
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

SOCS-1, a Negative Regulator of Cytokine Signaling, Is Frequently Silenced by Methylation in Multiple Myeloma

Blood
BiochemistryImmunologyCell BiologyHematology
2003English

Hypodiploid Multiple Myeloma Is Characterized by More Aggressive Molecular Markers Than Non-Hyperdiploid Multiple Myeloma

Haematologica
Hematology
2013English

Systemic Therapy With Oncolytic Myxoma Virus Cures Established Residual Multiple Myeloma in Mice

Molecular Therapy - Oncolytics
Cancer ResearchOncologyMolecular MedicinePharmacology
2016English

Is Early Palliative Care Feasible in Patients With Multiple Myeloma?

Journal of Pain and Symptom Management
NeurologyAnesthesiologyPain MedicineNursing
2017English

The TNFα Locus Is Altered in Monocytes From Patients With Systemic Lupus Erythematosus

Clinical Immunology
AllergyImmunology
2007English

FOXM1 Is a Therapeutic Target in High-Risk Multiple Myeloma

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2015English

Multiple Myeloma

Annals of Internal Medicine
Internal MedicineMedicine
1942English

Multiple Myeloma

Bone Marrow Transplantation
TransplantationHematology
2000English

Multiple Myeloma Treatment in the Elderly

International Journal of Hematologic Oncology
OncologyHematologyPharmacology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy